Human Neural Stem Cell Therapy for Chronic Ischemia Stroke

July 11, 2017

(Genetic Engineering & Biotechnology News) – Chronic disability after stroke represents a major unmet neurologic need. ReNeuron’s development of a human neural stem cell (hNSC) therapy for chronic disability after stroke is progressing through early clinical studies. A Phase I trial has recently been published, showing no safety concerns and some promising signs of efficacy. A single-arm Phase II multicenter trial in patients with stable upper-limb paresis has recently completed recruitment

Recommended Reading